COST given budget boost for FP7

COST, the European Cooperation in Science and Technology, will continue to be managed by the European Science Foundation (ESF) under the Seventh Framework Programme (FP7). The European Commission and ESF signed a contract to this effect at the end of July.

Under the Sixth Framework Programme (FP6), EU support for COST amounted to €80 million, a figure which is set to rise to €210 million under FP7. An additional €40 million could be added to the pot if a mid-term evaluation in 2010 is successful.

"The contract and the increase in funding is indeed a strong vote of confidence towards the ESF-COST cooperation," said Dr Martin Grabert, Director of the COST Office. "With this contract, we can truly capitalise on previous successes. We will not rest on our laurels, however, and continue to focus on cross-disciplinary initiatives and strengthening the synergy between the various research actors in Europe."

The bigger budget will allow COST to expand its activities and boost support for both the scientific and technical committees and the COST Actions (networks of researchers).

The contract sets out a series of work packages which reflect the increase in funding through new and expanded activities, the development of new ideas for interdisciplinary science initiatives and a greater exploitation of the European 'Near Neighbours' policy. There is also a stronger focus on outreach and communications.

"The negotiation of this contract and the transition between FP6 and FP7 were two challenging processes," commented David Weber, the ESF's Director of Administration and Finance, noting that the ESF's commitment to COST, coupled with its experience of managing such a complex operation, had been key to the successful completion of the agreement.

"I very much welcome the positive conclusion of the negotiations for the signature of the EC-ESF contract for COST," added Professor Francesco Fedi, President of the COST Committee of Senior Officials. "COST has always been a unique instrument with a strong role to play towards the development of the ERA. Typical COST features such as its flexibility and bottom-up approach make it a perfect platform for innovative ideas on the frontiers of science."

A recent independent review of the Commission-ESF COST contract for FP6 noted the high levels of satisfaction among users of COST and concluded that the switchover from the COST Action managed by the European to the COST Office run by the ESF had been largely successful.

Established in 1971, COST is now used by researchers in 35 European countries to cooperate in common research projects supported by national funds.

For more information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...